|
What’s Inside: 12th Annual GPC Download; Applications Open for State Business Tax Credit; Pfizer’s Recent Acquisition; and more.
|
We’re championing the progress made by California’s life science community and want to hear about your company’s latest scientific breakthrough, investment milestone, or commitment to creating positive change for our industry. We welcome all members to submit your story here for possible inclusion in an upcoming issue. |
|
|
What’s Happening at Biocom California
|
|
12th Annual Global Life Science Partnering Conference Highlights
We were delighted to convene 430 leading pharma and VC power players, biotech entrepreneurs, and influential dealmakers from 11 countries last month to facilitate crucial conversations at our annual Global Life Science Partnering Conference. Between keynote presentations with veteran dealmakers, 580+ meetings with prospective partners, and hearing from those on the frontlines of potential new treatments, we left with an immense feeling of pride for all that this industry accomplished together in 2021. An underlying theme this year was the talent and human capital you bring to your table, and the need for more inclusive leadership. Despite all of today’s challenges, this industry
continues to push the boundaries of what’s possible. We hope to see everyone back at the Lodge at Torrey Pines next year. View featured conference photos here.
|
|
Biocom California Advocates on Rare Disease Week
Rare Disease Week kicked off on February 28 and Biocom California joined industry leaders in showing support for patients across the country. In an effort to spread awareness of the work being done in our industry to find treatments, we developed an infographic on rare diseases which was delivered to congressional staff and shared on social media.
|
|
Celebrating a Legacy of Thermo Fisher Scientific Leadership
Biocom California would like to congratulate Mark Stevenson, executive vice president and chief operating officer, and Peter Silvester, senior vice president at Thermo Fisher Scientific, on their upcoming retirements. Stevenson and Silvester served on our Board of Directors and were critical in supporting our statewide expansion into the Los Angeles and Bay Area regions. They have had a tremendous impact on the life science industry throughout their tenure and will always be remembered for their leadership, spirit of collaboration, and for driving innovation. We wish them well in their next chapter.
|
|
|
Industry Intelligence & Member Moments
|
- AbbVie is continuing its partnership with Gedeon Richter, a Hungarian pharmaceutical company, to develop new dopamine receptive modulators to treat neuropsychiatric disorders
- AccendoWave was named one of the Top 50 Remote Monitoring Companies in AVIA Connect’s 2022 report. The company provides a non-pharmaceutical solution for pain via its software and EEG headband
- ARS Pharmaceuticals is filing an application with the FDA for its new drug, neffy, an epinephrine nasal spray to treat severe allergic reactions
- Eclipse Bioinnovations received $14M in Series A funding to expand its eCLIP technology, which helps companies and universities develop RNA drugs
- Element Biosciences launched new genome sequencing platform, AVITI
- Molecular Assemblies, a company that synthesizes and produces DNA, received $25.8M in Series B financing
- Novartis signed an agreement with Carisma Therapeutics to manufacture its HER2-targeted chimeric antigen receptor (CAR) macrophage cell therapy platform to treat tumors
- Nutcracker Therapeutics raised $167M in Series C funding to support development of mRNA medications for cancer and its biochip-based RNA manufacturing platform
- Pfizer completed its $6.7B acquisition of Arena Pharmaceuticals
- RefleXion Medical received $80M in financing for its emerging cancer treatment, BgRT (biology-guided radiotherapy), which incorporates positron-emission tomography (PET) imaging to track and treat multiple tumors
- Salk Institute researchers received a $3M Endeavor Award from The Mark Foundation to study more effective lung cancer treatments. The Salk team was one of four chosen out of 200 applicants worldwide
|
|
California Competes Tax Credit Applications Open
The California Competes Tax Credit (CCTC) is an income tax credit available to businesses that want to relocate in California or stay and grow in the state. Businesses of any industry, size, or location can compete for over $180M available in tax credits. GO-Biz will accept applications for the California Competes Tax Credit during March 7 – March 28. Prior to each application period, GO-Biz hosts webinars about the CCTC program. All businesses are encouraged to participate and view the Go-Biz webinars to receive instructions on how to apply.
|
|
Los Angeles Unified School District Keeps Masks
Many K-12 schools across the state are removing indoor mask requirements this week after the state lifted its mandate over the weekend. However, Los Angeles Unified School District has stated they will continue to enforce the mask mandate, at least temporarily, working with labor partners and other stakeholders to transition from required indoor masking to a strong recommendation for indoor masking.
|
|
Biocom California
For over 25 years, Biocom California has helped move the life science industry forward with transformative resources that enable companies to make meaningful connections. With a membership base of over 1,500 companies, we connect our members to each other so they can collaborate and work stronger and smarter together. We connect organizations to capital investment and purchasing solutions so they can grow faster and work more efficiently. We’re their link to advocacy that fights for innovation and we provide an environment where their business and talent can thrive. Biocom California is how the life science industry gets connected.
|
|
|
